These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26443873)

  • 1. Synergistic inhibition of PARP-1 and NF-κB signaling downregulates immune response against recombinant AAV2 vectors during hepatic gene therapy.
    Hareendran S; Ramakrishna B; Jayandharan GR
    Eur J Immunol; 2016 Jan; 46(1):154-66. PubMed ID: 26443873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes.
    Li H; Murphy SL; Giles-Davis W; Edmonson S; Xiang Z; Li Y; Lasaro MO; High KA; Ertl HC
    Mol Ther; 2007 Apr; 15(4):792-800. PubMed ID: 17245353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells.
    Xin KQ; Mizukami H; Urabe M; Toda Y; Shinoda K; Yoshida A; Oomura K; Kojima Y; Ichino M; Klinman D; Ozawa K; Okuda K
    J Virol; 2006 Dec; 80(24):11899-910. PubMed ID: 17005662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement is an essential component of the immune response to adeno-associated virus vectors.
    Zaiss AK; Cotter MJ; White LR; Clark SA; Wong NC; Holers VM; Bartlett JS; Muruve DA
    J Virol; 2008 Mar; 82(6):2727-40. PubMed ID: 18199646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the NF-kappaB pathway by adeno-associated virus (AAV) vectors and its implications in immune response and gene therapy.
    Jayandharan GR; Aslanidi G; Martino AT; Jahn SC; Perrin GQ; Herzog RW; Srivastava A
    Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3743-8. PubMed ID: 21321191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liver.
    Martino AT; Suzuki M; Markusic DM; Zolotukhin I; Ryals RC; Moghimi B; Ertl HC; Muruve DA; Lee B; Herzog RW
    Blood; 2011 Jun; 117(24):6459-68. PubMed ID: 21474674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B.
    George LA; Ragni MV; Rasko JEJ; Raffini LJ; Samelson-Jones BJ; Ozelo M; Hazbon M; Runowski AR; Wellman JA; Wachtel K; Chen Y; Anguela XM; Kuranda K; Mingozzi F; High KA
    Mol Ther; 2020 Sep; 28(9):2073-2082. PubMed ID: 32559433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient AAV1-AAV2 hybrid vector for gene therapy of hemophilia.
    Hauck B; Xu RR; Xie J; Wu W; Ding Q; Sipler M; Wang H; Chen L; Wright JF; Xiao W
    Hum Gene Ther; 2006 Jan; 17(1):46-54. PubMed ID: 16409124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle-directed gene therapy for hemophilia B with more efficient and less immunogenic AAV vectors.
    Wang L; Louboutin JP; Bell P; Greig JA; Li Y; Wu D; Wilson JM
    J Thromb Haemost; 2011 Oct; 9(10):2009-19. PubMed ID: 21883883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the cellular unfolded protein response by recombinant adeno-associated virus vectors.
    Balakrishnan B; Sen D; Hareendran S; Roshini V; David S; Srivastava A; Jayandharan GR
    PLoS One; 2013; 8(1):e53845. PubMed ID: 23320106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice.
    Scallan CD; Jiang H; Liu T; Patarroyo-White S; Sommer JM; Zhou S; Couto LB; Pierce GF
    Blood; 2006 Mar; 107(5):1810-7. PubMed ID: 16249376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of poly(ADP-ribose) polymerase 1 on integration of the adeno-associated viral vector genome.
    Romanova LG; Zacharias J; Cannon ML; Philpott NJ
    J Gene Med; 2011 Jun; 13(6):342-52. PubMed ID: 21674737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Engineering of Adeno-Associated Virus Capsid Improves Its Therapeutic Gene Transfer in Murine Models of Hemophilia and Retinal Degeneration.
    Mary B; Maurya S; Kumar M; Bammidi S; Kumar V; Jayandharan GR
    Mol Pharm; 2019 Nov; 16(11):4738-4750. PubMed ID: 31596095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
    Shi W; Arnold GS; Bartlett JS
    Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-efficiency transduction and correction of murine hemophilia B using AAV2 vectors devoid of multiple surface-exposed tyrosines.
    Markusic DM; Herzog RW; Aslanidi GV; Hoffman BE; Li B; Li M; Jayandharan GR; Ling C; Zolotukhin I; Ma W; Zolotukhin S; Srivastava A; Zhong L
    Mol Ther; 2010 Dec; 18(12):2048-56. PubMed ID: 20736929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged susceptibility to antibody-mediated neutralization for adeno-associated vectors targeted to the liver.
    Murphy SL; Li H; Zhou S; Schlachterman A; High KA
    Mol Ther; 2008 Jan; 16(1):138-45. PubMed ID: 17955024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic-T-lymphocyte-mediated elimination of target cells transduced with engineered adeno-associated virus type 2 vector in vivo.
    Li C; Hirsch M; DiPrimio N; Asokan A; Goudy K; Tisch R; Samulski RJ
    J Virol; 2009 Jul; 83(13):6817-24. PubMed ID: 19369348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adeno-associated virus capsid structure drives CD4-dependent CD8+ T cell response to vector encoded proteins.
    Mays LE; Vandenberghe LH; Xiao R; Bell P; Nam HJ; Agbandje-McKenna M; Wilson JM
    J Immunol; 2009 May; 182(10):6051-60. PubMed ID: 19414756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis.
    Martin-Oliva D; Aguilar-Quesada R; O'valle F; Muñoz-Gámez JA; Martínez-Romero R; García Del Moral R; Ruiz de Almodóvar JM; Villuendas R; Piris MA; Oliver FJ
    Cancer Res; 2006 Jun; 66(11):5744-56. PubMed ID: 16740713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy.
    Vandendriessche T; Thorrez L; Acosta-Sanchez A; Petrus I; Wang L; Ma L; DE Waele L; Iwasaki Y; Gillijns V; Wilson JM; Collen D; Chuah MK
    J Thromb Haemost; 2007 Jan; 5(1):16-24. PubMed ID: 17002653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.